Literature DB >> 27073501

Downregulation of LSD1 suppresses the proliferation, tumorigenicity and invasion of papillary thyroid carcinoma K1 cells.

Ling-Ling Kong1, Dong-Mei Man2, Tian Wang3, Guo-An Zhang1, Wen Cui1.   

Abstract

The present study aimed to evaluate the effects of lysine-specific demethylase 1 (LSD1) downregulation, induced by small interfering RNA (siRNA) transfection, on the proliferation, colony formation, migration and invasion of the papillary thyroid carcinoma K1 cell line. The siRNA targeting LSD1 and scrambled non-targeting siRNA were each transfected into papillary thyroid carcinoma K1 cells. Downregulation of LSD1 mRNA and protein level was evaluated by reverse transcription-quantitative polymerase chain reaction, and immunocytochemical (ICC) analysis and western blotting, respectively. A Cell Counting kit-8 assay was applied to estimate the effect of LSD1-siRNA on cell growth. Migration and invasion abilities were estimated by Transwell chamber assay. A soft agar colony formation assay was performed to estimate the effect of LSD1-siRNA on tumorigenicity in vitro. ICC data showed that LSD1 protein was strongly expressed in the blank and control K1 cells compared with the LSD1-siRNA cells (F=15.192, P<0.01). Compared with the control cells, cells transfected with siRNA targeting LSD1 exhibited significant downregulation of LSD1 mRNA (t=6.845, P<0.01) and protein (F=53.764, P<0.01) levels. siRNA targeting LSD1 also downregulated cell proliferation following transfection for 24, 48 and 72 h (t=4.777, P<0.001; t=3.302, P=0.003; and t=3.017, P=0.006, respectively). Compared with the control group, the amount of cell invasion was gradually reduced in the LSD1-siRNA group (t=12.301, P<0.01). The number of migrating cells was significantly higher in the negative control group compared with the LSD1-siRNA group (t=7.911, P<0.01), and the ability of colony formation in the LSD1-siRNA cells was notably reduced in the soft agar formation assay (t=3.612, P=0.005). siRNA targeting LSD1 efficiently inhibits the proliferation, colony formation, migration and invasion of papillary thyroid carcinoma K1 cells.

Entities:  

Keywords:  Transwell chamber assay; lysine-specific demethylase 1; papillary thyroid carcinoma; small interfering RNA; soft agar colony formation assay

Year:  2016        PMID: 27073501      PMCID: PMC4812116          DOI: 10.3892/ol.2016.4244

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.

Authors:  Ivan Garcia-Bassets; Young-Soo Kwon; Francesca Telese; Gratien G Prefontaine; Kasey R Hutt; Christine S Cheng; Bong-Gun Ju; Kenneth A Ohgi; Jianxun Wang; Laure Escoubet-Lozach; David W Rose; Christopher K Glass; Xiang-Dong Fu; Michael G Rosenfeld
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

3.  Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Authors:  N Gopalakrishna Iyer; Luc G T Morris; R Michael Tuttle; Ashok R Shaha; Ian Ganly
Journal:  Cancer       Date:  2011-03-22       Impact factor: 6.860

4.  Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates.

Authors:  Allen S Ho; Louise Davies; Iain J Nixon; Frank L Palmer; Laura Y Wang; Snehal G Patel; Ian Ganly; Richard J Wong; R Michael Tuttle; Luc G T Morris
Journal:  Cancer       Date:  2015-02-24       Impact factor: 6.860

5.  High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors.

Authors:  Venkataswamy Sorna; Emily R Theisen; Bret Stephens; Steven L Warner; David J Bearss; Hariprasad Vankayalapati; Sunil Sharma
Journal:  J Med Chem       Date:  2013-11-23       Impact factor: 7.446

6.  Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.

Authors:  Carole Spencer; Ivana Petrovic; Shireen Fatemi; Jonathan LoPresti
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

Review 7.  Perspectives on natural product epigenetic modulators in chemical biology and medicine.

Authors:  Fanny L Cherblanc; Robert W M Davidson; Paolo Di Fruscia; Nitipol Srimongkolpithak; Matthew J Fuchter
Journal:  Nat Prod Rep       Date:  2013-05       Impact factor: 13.423

8.  Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer.

Authors:  Tangfeng Lv; Dongmei Yuan; Xiaohui Miao; Yanling Lv; Ping Zhan; Xiaokun Shen; Yong Song
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

9.  Lysine-specific demethylase 1 (LSD1/KDM1A) contributes to colorectal tumorigenesis via activation of the Wnt/β-catenin pathway by down-regulating Dickkopf-1 (DKK1) [corrected].

Authors:  Zebin Huang; Shangze Li; Wei Song; Xin Li; Qinshan Li; Zeyan Zhang; Yongqing Han; Xiaodong Zhang; Shiying Miao; Runlei Du; Linfang Wang
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Analysis of the levels of lysine-specific demethylase 1 (LSD1) mRNA in human ovarian tumors and the effects of chemical LSD1 inhibitors in ovarian cancer cell lines.

Authors:  Sergiy Konovalov; Ivan Garcia-Bassets
Journal:  J Ovarian Res       Date:  2013-10-29       Impact factor: 4.234

View more
  2 in total

1.  Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.

Authors:  WenQian Zhang; Wei Sun; Yuan Qin; CangHao Wu; Liang He; Ting Zhang; Liang Shao; Hao Zhang; Ping Zhang
Journal:  J Cell Mol Med       Date:  2019-06-18       Impact factor: 5.310

2.  Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma.

Authors:  Jing Zeng; Xiao Ma; Jinjing Wang; Ran Liu; Yun Shao; Yanwei Hou; Zhiyuan Li; Yi Fang
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.